Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
TERARECON, INC.
AMPRONIX

Intensity Modulated Proton Therapy System Receives Clearance

By Medimaging International staff writers
Posted on 21 Jan 2014
Image: Inside the treatment room of the ProBeam proton therapy system (Photo courtesy of Varian).
Image: Inside the treatment room of the ProBeam proton therapy system (Photo courtesy of Varian).
A proton therapy system provides clinicians with alternatives to minimize dose to healthy tissue in the course of delivering proton therapy treatments for cancer. The system’s scanning beam technology enables intensity-modulated proton therapy (IMPT) by modulating dose levels on a targeted basis throughout the treatment area.

Varian Medical Systems (Palo Alto, VA, USA) has received US Food and Drug Administration (FDA) 510(k) clearance for its updated ProBeam proton therapy system.

Irradiations from multiple angles in the technology are combined in an optimum way to enhance control of dose distributions. Moreover, scanning beam technology eliminates the time-consuming need to manually insert separate shaping accessories for each beam angle to match the beam to the shape of the tumor.

Varian’s scanning beam IMPT technology has been installed in the Rinecker Proton Therapy Center (Munich, Germany), which has now treated over 1,500 patients. Varian also has contracts to install ProBeam systems at six sites: four in the United States, one in Saudi Arabia, and one in Russia.

Varian Medical Systems is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing cancer clinics, radiotherapy centers, and medical oncology practices.

Related Links:

Varian Medical Systems



RTI ELECTRONICS AB
SuperSonic Imagine
RADCAL

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

MRI

view channel
Image: The Accent MRI pacemaker and Tendril MRI lead (Photo courtesy of St. Jude Medical).

US Patent Allows Full-Body MRI Technology for Use with Pacemakers

A California hospital is first in the United States to conduct magnetic resonance imaging (MRI) of a patient implanted with a new MRI-compatible pacemaker. Cardiothoracic surgeon Raymond Schaerf, MD... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.